Skip to content
星期六, 10 十二月, 2022
Local delivery therapy of Cerebraca® Wafer being highlighted in the natural review
Case report – Cerebraca® Wafer implantation combined with CIK therapy for the treatment of recurrent Glioblastoma revealed superior clinical outcome (overall survival extended for more than 24 months).
Case report – Cerebraca® Wafer implantation for the treatment of un-resectable cervical spine Glioblastoma resulted in the tumor regression.
Outstanding clinical outcomes were published in various journals. We have listed as follows:
Everfront Biotech In